Skip to main content
Signal8

ANDREWS DEBORAH J

SEC insider (Form 3/4/5 filer). CIK 0001325697. Chief Financial Officer & EVP at STAAR SURGICAL CO (STAA) and 1 other issuer. 20 reported Form 4/5 transactions since Sep 2024; latest on Aug 14, 2026. Located in LAKE FOREST, CA.

Companies ANDREWS DEBORAH J has filed insider reports for

  • STAAR SURGICAL CO (STAA): Officer, Chief Financial Officer & EVP
  • Lineage Cell Therapeutics, Inc. (LCTX): Director
ANDREWS DEBORAH J profile photo

ANDREWS DEBORAH J

CIK: 0001325697

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)5 (25.0%)

Derivative conversions

Awards (A)10 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)5 (25.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

STAAR SURGICAL CO logo
STAA

STAAR SURGICAL CO

Officer
Lineage Cell Therapeutics, Inc. logo
LCTX

Lineage Cell Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (20 total)

  • STAAR SURGICAL CO logo
    STAA

    STAAR SURGICAL CO

    Aug 14, 2026
    Award

    Performance Stock Option (right to buy)

    Direct
    29.2K shares-
  • STAAR SURGICAL CO logo
    STAA

    STAAR SURGICAL CO

    Aug 14, 2026
    Award

    Stock Option (right to buy)

    Direct
    9K shares-
  • STAAR SURGICAL CO logo
    STAA

    STAAR SURGICAL CO

    Aug 14, 2026
    Award

    Restricted Stock Units

    Direct
    5K shares-
  • STAAR SURGICAL CO logo
    STAA

    STAAR SURGICAL CO

    Aug 14, 2026
    Exercise
    Direct
    5.2K shares-
  • STAAR SURGICAL CO logo
    STAA

    STAAR SURGICAL CO

    Aug 14, 2026
    Tax Payment
    Direct
    2.7K shares at avg. $26.18$70K
  • STAAR SURGICAL CO logo
    STAA

    STAAR SURGICAL CO

    Jul 31, 2026
    Exercise
    Direct
    20.8K shares-
  • STAAR SURGICAL CO logo
    STAA

    STAAR SURGICAL CO

    Jul 31, 2026
    Tax Payment
    Direct
    10.6K shares at avg. $24.36$258K
  • Lineage Cell Therapeutics, Inc. logo
    LCTX

    Lineage Cell Therapeutics, Inc.

    Jul 1, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    125K shares-
  • STAAR SURGICAL CO logo
    STAA

    STAAR SURGICAL CO

    Jun 25, 2026
    Exercise
    Direct
    14K shares-
  • STAAR SURGICAL CO logo
    STAA

    STAAR SURGICAL CO

    Jun 25, 2026
    Tax Payment
    Direct
    6.5K shares at avg. $31.21$202K

1-10 of 20